Zimmer Biomet (NYSE:ZBH) announced today that it received CE mark approval in Europe for its Persona revision knee system.
Compass has also deployed the Vertiv™ Next Predict service platform, leveraging predictive analytics to enable the company to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback